Laboratoire de Bactériologie - CHU de Strasbourg - France
Strasbourg, 67091, France
Location status: Recruiting
Location contact
Émilie TALAGRAND-REBOUL, MD
CONTACT
Émilie TALAGRAND-REBOUL, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07335965
Recurrent borreliosis (RB) is a bacterial infection transmitted by ticks or lice. These infections occur in both temperate and tropical regions, but are rare in Australia and Antarctica. Due to climate change, the areas inhabited by the vectors of these infections are shifting, and the number of at-risk regions has significantly increased in recent years. More than twenty RB species have been described, responsible for variable clinical manifestations including fever, myalgia, digestive disorders, and sometimes neurological symptoms. Tick-borne RB represents a major public health problem, particularly in Africa. Mortality from these infections ranges from 5% to 10%. In recent years, diagnostic techniques have evolved. Microscopic diagnosis was initially the gold standard but had only moderate sensitivity and exhibited inter-operator variability. The advent of molecular biology now allows for increased sensitivity with excellent specificity and also enables the identification of the causative species.
A few cases have been described in France, consisting mainly of case reports. Therefore, this study will provide a comparative description, within a series, of cases diagnosed in France: symptoms, patients' countries of origin, Borrelia species, diagnostic techniques, management, and patient outcomes.
Interested in participating?
Request Info1 year and older
All sexes
Observational
Strasbourg, 67091, France
Location status: Recruiting
Émilie TALAGRAND-REBOUL, MD
CONTACT
Émilie TALAGRAND-REBOUL, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 12 years
This study does not include any evaluation, but simply describes cases diagnosed in France: symptoms, patients' countries of origin, Borrelia species, diagnostic techniques, and treatment.
Contact information is provided by the study sponsor or research team.
University Hospital, Strasbourg, France
Other
Study of the Clinical, Microbiological, and Epidemiological Characteristics of Recurrent Imported Borreliosis Confirmed by the Borrelia National Reference Center
Acronym: BORRECUR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07683104
Animal Diseases, Bacterial Infections
Bethesda, Maryland, United States
View Trial DetailsNCT06045416
Bacterial Infections, Bacterial Infections and Mycoses
Zurich, Switzerland
View Trial DetailsNCT07343089
Bacterial Infections, Bacterial Infections and Mycoses
Strasbourg, France
View Trial DetailsNCT07562087
Bacterial Infections, Bacterial Infections and Mycoses
Pikesville, Maryland, United States
View Trial Details